Century Therapeutics, Inc. (IPSC) vs SAB Biotherapeutics, Inc. (SABS)
- Century Therapeutics, Inc. IPSC 1.68 +11.26%
- SAB Biotherapeutics, Inc. SABS 3.00 +2.04%
Century Therapeutics, Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and SAB Biotherapeutics, Inc. are of similar size ($273.4M and $267.5M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −60.3%. Across the 14 metrics below, SAB Biotherapeutics, Inc. leads on 8 and Century Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | IPSC | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (49.65%) | (34.27%) | (51.96%) |
| Return on assets | (38.41%) | (28.97%) | (46.06%) |
| Return on invested capital | (64.92%) | (38.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack